-
-
In this issue: NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
-
This study examined patients' bath basins as a possible reservoir for bacterial colonization and a risk factor for subsequent hospital-acquired infections.
-
Intensive insulin therapy in the ICU is a dynamic and controversial issue that has played out in the medical literature, at the bedside, and in the offices of policy makers over the last 8 years.
-
This study was designed to determine whether intensive glucose control in ICU patients reduces mortality at 90 days. Secondary outcomes included survival time during the 90 days, cause-specific death, duration of mechanical ventilation, need for renal replacement therapy, and hospital and ICU lengths of stay.
-
The ICU is commonly viewed as a stressful environment. While common, stress responses are likely to vary over time, between individuals, and as a result of the context in which they occur.
-
Colonization of the respiratory tract and other sites with Candida species is common in ICU patients but it is unclear how often these species cause pneumonia that warrants antifungal therapy.
-
Along with yearly vaccination, the U.S. Centers for Disease Control and Prevention (CDC) recommend the use of personal protective equipment (PPE) by health care workers (HCWs) to prevent influenza infection in the ICU.
-
-
Fluid therapy is an integral aspect of trauma resuscitation.